98 related articles for article (PubMed ID: 14662412)
1. Expression of SGLT-1 in preneoplastic and neoplastic lesions of the head and neck.
Helmke BM; Reisser C; Idzko M; Dyckhoff G; Herold-Mende C
Oral Oncol; 2004 Jan; 40(1):28-35. PubMed ID: 14662412
[TBL] [Abstract][Full Text] [Related]
2. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck.
Reisser C; Eichhorn K; Herold-Mende C; Born AI; Bannasch P
Int J Cancer; 1999 Jan; 80(2):194-8. PubMed ID: 9935199
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
4. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
5. SGLT gene expression in primary lung cancers and their metastatic lesions.
Ishikawa N; Oguri T; Isobe T; Fujitaka K; Kohno N
Jpn J Cancer Res; 2001 Aug; 92(8):874-9. PubMed ID: 11509120
[TBL] [Abstract][Full Text] [Related]
6. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
Szczepanski MJ; DeLeo AB; Łuczak M; Molinska-Glura M; Misiak J; Szarzynska B; Dworacki G; Zagor M; Rozwadowska N; Kurpisz M; Krzeski A; Kruk-Zagajewska A; Kopec T; Banaszewski J; Whiteside TL
Oral Oncol; 2013 Feb; 49(2):144-51. PubMed ID: 22944049
[TBL] [Abstract][Full Text] [Related]
7. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
[TBL] [Abstract][Full Text] [Related]
9. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K
Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
[TBL] [Abstract][Full Text] [Related]
10. The effect of massive small bowel resection and oral epidermal growth factor therapy on SGLT-1 distribution in rabbit distal remnant.
Chung BM; Wallace LE; Winkfein RK; O'Loughlin EV; Hardin JA; Gall DG
Pediatr Res; 2004 Jan; 55(1):19-26. PubMed ID: 14561780
[TBL] [Abstract][Full Text] [Related]
11. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
12. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma.
Kikuchi K; Noguchi A; Kasajima R; Miyagi Y; Hoshino D; Koshikawa N; Kubota A; Yokose T; Takano Y
Tumour Biol; 2015 Sep; 36(10):7865-72. PubMed ID: 25946975
[TBL] [Abstract][Full Text] [Related]
13. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells.
Martone T; Bellone G; Pagano M; Beatrice F; Palonta F; Emanuelli G; Cortesina G
Head Neck; 2004 Jun; 26(6):494-503. PubMed ID: 15162350
[TBL] [Abstract][Full Text] [Related]
15. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
[TBL] [Abstract][Full Text] [Related]
16. COX-2 expression in dysplasia of the head and neck: correlation with elF4E.
Nathan CO; Leskov IL; Lin M; Abreo FW; Shi R; Hartman GH; Glass J
Cancer; 2001 Oct; 92(7):1888-95. PubMed ID: 11745262
[TBL] [Abstract][Full Text] [Related]
17. Expression characteristics and relevance of sodium glucose cotransporter-1 in mammalian renal tubulogenesis.
Yang Q; Tian Y; Wada J; Kashihara N; Wallner E; Peterson D; Kanwar YS
Am J Physiol Renal Physiol; 2000 Oct; 279(4):F765-77. PubMed ID: 10997927
[TBL] [Abstract][Full Text] [Related]
18. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
19. Expression of connective tissue growth factor (CTGF/CCN2) in head and neck squamous cell carcinoma.
Mullis TC; Tang X; Chong KT
J Clin Pathol; 2008 May; 61(5):606-10. PubMed ID: 18441156
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
